BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37480649)

  • 1. Extraprostatic incidental findings on prostate mpMRI: A pictorial review from the ESUR junior network.
    Ponsiglione A; Campo I; Sachs C; Sofia C; Álvarez-Hornia Pérez E; Ciabattoni R; Sharaf DE; Causa-Andrieu P; Stanzione A; Cuocolo R; Zawaideh J; Brembilla G
    Eur J Radiol; 2023 Sep; 166():110984. PubMed ID: 37480649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for the Prediction of Extraprostatic Disease-A Risk Model for Patient-tailored Risk Stratification When Planning Radical Prostatectomy.
    Nyarangi-Dix J; Wiesenfarth M; Bonekamp D; Hitthaler B; Schütz V; Dieffenbacher S; Mueller-Wolf M; Roth W; Stenzinger A; Duensing S; Roethke M; Teber D; Schlemmer HP; Hohenfellner M; Radtke JP
    Eur Urol Focus; 2020 Nov; 6(6):1205-1212. PubMed ID: 30477971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Relationship between PI-RADS Categories and Incidental Findings in Multiparametric Prostate MRI.
    Ediz SS; Gunduz N
    J Coll Physicians Surg Pak; 2021 Sep; 31(9):1030-1034. PubMed ID: 34500516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidental findings on multiparametric MRI performed for evaluation of prostate cancer.
    Sherrer RL; Lai WS; Thomas JV; Nix JW; Rais-Bahrami S
    Abdom Radiol (NY); 2018 Mar; 43(3):696-701. PubMed ID: 28677001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 2: Interpretation.
    Israël B; Leest MV; Sedelaar M; Padhani AR; Zámecnik P; Barentsz JO
    Eur Urol; 2020 Apr; 77(4):469-480. PubMed ID: 31767492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of multiparametric prostate MRI in the management of prostate cancer.
    O'Connor LP; Lebastchi AH; Horuz R; Rastinehad AR; Siddiqui MM; Grummet J; Kastner C; Ahmed HU; Pinto PA; Turkbey B
    World J Urol; 2021 Mar; 39(3):651-659. PubMed ID: 32583039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors Influencing Variability in the Performance of Multiparametric Magnetic Resonance Imaging in Detecting Clinically Significant Prostate Cancer: A Systematic Literature Review.
    Stabile A; Giganti F; Kasivisvanathan V; Giannarini G; Moore CM; Padhani AR; Panebianco V; Rosenkrantz AB; Salomon G; Turkbey B; Villeirs G; Barentsz JO
    Eur Urol Oncol; 2020 Apr; 3(2):145-167. PubMed ID: 32192942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidental bladder cancers found on multiparametric MRI of the prostate gland: a single center experience.
    Rayn KN; Hale GR; Bloom JB; Gold SA; Carvalho FLF; Mehralivand S; Czarniecki M; Wood BJ; Merino MJ; Choyke P; Türkbey B; Pinto PA; Agarwal PK
    Diagn Interv Radiol; 2018 Sep; 24(5):316-320. PubMed ID: 30211685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The primacy of multiparametric MRI in men with suspected prostate cancer.
    Richenberg J; Løgager V; Panebianco V; Rouviere O; Villeirs G; Schoots IG
    Eur Radiol; 2019 Dec; 29(12):6940-6952. PubMed ID: 31172275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Accuracy of Single-plane Biparametric and Multiparametric Magnetic Resonance Imaging in Prostate Cancer: A Randomized Noninferiority Trial in Biopsy-naïve Men.
    Russo F; Mazzetti S; Regge D; Ambrosini I; Giannini V; Manfredi M; De Luca S; Bollito E; Porpiglia F
    Eur Urol Oncol; 2021 Dec; 4(6):855-862. PubMed ID: 33893066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining prostate health index and multiparametric magnetic resonance imaging may better predict extraprostatic extension after radical prostatectomy.
    Huang YP; Lin TP; Shen SH; Cheng WM; Huang TH; Huang IS; Fan YH; Lin CC; Huang EYH; Chung HJ; Lu SH; Chang YH; Lin ATL; Huang WJ
    J Chin Med Assoc; 2023 Jan; 86(1):52-56. PubMed ID: 36346752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study of the diagnostic utility of
    Vlachostergios PJ; Niaz MJ; Thomas C; Christos PJ; Osborne JR; Margolis DJA; Khani F; Bander NH; Scherr DS; Tagawa ST
    Prostate; 2022 Mar; 82(4):483-492. PubMed ID: 34985786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate Indeterminate Lesions on Magnetic Resonance Imaging-Biopsy Versus Surveillance: A Literature Review.
    Gómez Rivas J; Giganti F; Álvarez-Maestro M; Freire MJ; Kasivisvanathan V; Martinez-Piñeiro L; Emberton M
    Eur Urol Focus; 2019 Sep; 5(5):799-806. PubMed ID: 29525382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy.
    Mannaerts CK; Gayet M; Verbeek JF; Engelbrecht MRW; Savci-Heijink CD; Jager GJ; Gielens MPM; van der Linden H; Beerlage HP; de Reijke TM; Wijkstra H; Roobol MJ
    Eur Urol Oncol; 2018 Jun; 1(2):109-117. PubMed ID: 31100233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study.
    Brown LC; Ahmed HU; Faria R; El-Shater Bosaily A; Gabe R; Kaplan RS; Parmar M; Collaco-Moraes Y; Ward K; Hindley RG; Freeman A; Kirkham A; Oldroyd R; Parker C; Bott S; Burns-Cox N; Dudderidge T; Ghei M; Henderson A; Persad R; Rosario DJ; Shergill I; Winkler M; Soares M; Spackman E; Sculpher M; Emberton M
    Health Technol Assess; 2018 Jul; 22(39):1-176. PubMed ID: 30040065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abbreviated Protocols
    Stanzione A; Ponsiglione A; Cuocolo R; Cocozza S; Picchi SG; Stilo S; Persico F; Creta M; Longo N; Imbriaco M
    Anticancer Res; 2019 Aug; 39(8):4449-4454. PubMed ID: 31366543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the accuracy of multiparametric MRI for predicting prostate cancer pathology and tumour staging in the real world: an multicentre study.
    Kam J; Yuminaga Y; Krelle M; Gavin D; Koschel S; Aluwihare K; Sutherland T; Skinner S; Brennan J; Wong LM; Louie-Johnsun M
    BJU Int; 2019 Aug; 124(2):297-301. PubMed ID: 30714285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of multiparametric magnetic resonance imaging in prostate cancer active surveillance.
    Glass AS; Dall'Era MA
    BJU Int; 2019 Nov; 124(5):730-737. PubMed ID: 30740876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and clinical significance of incidental findings on multiparametric prostate MRI.
    Cutaia G; Tosto G; Cannella R; Bruno A; Leto C; Salvaggio L; Cutaia S; Lombardo FP; Dispensa N; Giambelluca D; Midiri M; Salvaggio G
    Radiol Med; 2020 Feb; 125(2):204-213. PubMed ID: 31784928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of Targeted Prostate Biopsy by Adding Micro-Ultrasound to the Magnetic Resonance Imaging Pathway.
    Wiemer L; Hollenbach M; Heckmann R; Kittner B; Plage H; Reimann M; Asbach P; Friedersdorff F; Schlomm T; Hofbauer S; Cash H
    Eur Urol Focus; 2021 Nov; 7(6):1292-1299. PubMed ID: 32654967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.